Stem cells raise enormous hope and expectations
for regenerative medicine and targeted therapy.
We study the (patho)physiology of blood and colon stem cells during clonal evolution from normal to malignant. Especially early transformative events
and single mutations on their transition into premalignancy are in the center of interest.
Stem cells raise enormous hope and expectations for regenerative medicine and targeted therapy. We study the (patho)physiology of blood and colon stem cells during clonal evolution from normal to malignant. Especially early transformative events and single mutations on their transition into premalignancy are in the center of interest.
